Sulfanilamide

Sulfanilamide

SCHEMBL7658884

CC(C)(O)c1coc(S(N)(=O)=O)c1.CCO.Nc1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Sulfanilamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 P00918 14/20 0.42
CA12 O43570 6/20 0.42
CA9 Q16790 6/20 0.42
CA1 P00915 5/20 0.42
CA14 Q9ULX7 4/20 0.42
USP2 O75604 1/20 0.42
TSHR P16473 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA13 Q8N1Q1 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
AGO2 Q9UKV8 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
PTGS2 P35354 2/20 0.38
PTGS1 P23219 1/20 0.38
NLRP3 Q96P20 2/20 0.38
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6869002 0.82 NLRP3 (0.45) CA2NLRP3
SCHEMBL27430354 0.81 NLRP3 (0.44) CA2NLRP3
Sulfanilamide SCHEMBL419065 0.76 CA2 (0.74) CA2CA12CA9CA1CA14
SCHEMBL3637984 0.69 CA2 (0.55) CA2CA12CA9CA1CA14
Sulfanilamide SCHEMBL7766519 0.69 CA2 (0.61) CA2CA12CA9CA1CA14
SCHEMBL19506100 0.68 NLRP3 (0.46) CA2NLRP3
Sulfanilamide SCHEMBL629179 0.67 CA2 (0.77) CA2CA12CA9CA1CA14
Sulfanilamide SCHEMBL2215151 0.67 CA2 (0.77) CA2CA12CA9CA1CA14
Sulfanilamide SCHEMBL28201481 0.67 CA2 (0.85) CA2CA12CA9CA1CA14
Sulfanilamide SCHEMBL28706270 0.65 CA2 (0.55) CA2CA12CA9CA1CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214087-A1 COMBINATION TREATMENT WITH IL-1RA AND COMPOUNDS THAT INHIBIT IL-1 PROCESSING AND RELEASE Pfizer Products Inc. (US) 2002-06-19 EP disclosed
WO-2001019390-A1 COMBINATION TREATMENT WITH IL-1RA AND DIARYL SULPHONYL UREA COMPOUNDS PFIZER PRODUCTS INC. (US) 2001-03-22 WO disclosed
US-6022984-A Efficient synthesis of furan sulfonamide compounds useful in the synthesis of new IL-1 inhibitors PFIZER INC. (US) 2000-02-08 US disclosed
EP-0976742-A1 A synthesis of furan sulfonamide compounds useful in the synthesis of IL-1 inhibitors Pfizer Products Inc. (US) 2000-02-02 EP disclosed